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Abstract
Background: Purinergic receptors are expressed in the ovary of different species; their physiological roles remain to be 
elucidated. UTP-sensitive P2Y receptor activity may regulate cell proliferation. The aim of the present work was to study 
the functional expression of these receptors in theca/interstitial cells (TIC).
Methods: TIC were isolated by centrifugation in a Percoll gradient. P2Y receptors and cellular markers in TIC were 
detected by RT-PCR and Western blot. Intracellular calcium mobilization induced by purinergic drugs was evaluated by 
fluorescence microscopy, phosphorylation of MAPK p44/p42 and of cAMP response element binding protein (CREB) 
was determined by Western blot and proliferation was quantified by [3H]-thymidine incorporation into DNA.
Results: RT-PCR showed expression of p2y2r and p2y6r transcripts, expression of the corresponding proteins was 
confirmed. UTP and UDP, agonists for P2Y2 and P2Y6 receptors, induced an intracellular calcium increase with a 
maximum of more than 400% and 200% of basal level, respectively. The response elicited by UTP had an EC50 of 3.5 +/
- 1.01 μM, while that for UDP was 3.24 +/- 0.82 μM. To explore components of the pathway activated by these 
receptors, we evaluated the phosphorylation induced by UTP or UDP of MAPK p44 and p42. It was found that UTP 
increased MAPK phosphorylation by up to 550% with an EC50 of 3.34 +/- 0.92 and 1.41 +/- 0.67 μM, for p44 and p42, 
respectively; these increases were blocked by suramin. UDP also induced p44/p42 phosphorylation, but at high 
concentrations. Phosphorylation of p44/p42 was dependent on PKC and intracellular calcium. To explore possible roles 
of this pathway in cell physiology, cell proliferation and hCG-induced CREB-phosphorylation assays were performed; 
results showed that agonists increased cell proliferation and prevented CREB-phosphorylation.
Conclusion: Here, it is shown that UTP-sensitive P2Y receptors are expressed in cultured TIC and that these receptors 
had the ability to activate mitogenic signaling pathways and to promote cell proliferation, as well as to prevent CREB-
phosphorylation by hCG. Regulation of TIC proliferation and steroidogenesis is relevant in ovarian pathophysiology 
since theca hyperplasia is involved in polycystic ovarian syndrome. Purinergic receptors described might represent an 
important new set of molecular therapeutic targets.
Background
Theca cells form a multilayer cover that surrounds the
follicle beginning in its early developmental stages. The
main physiological roles recognized for theca cells are the
initial steps in the steroidogenic process; specifically,
these cells convert acetate or cholesterol to androgens [1],
which are secreted into the intra-follicular medium and
taken up by granulosa cells to serve as substrate for estro-
gen synthesis. In addition, theca cells could be an impor-
tant signal integrator and regulator of aspects of follicular
growth, because it represents the last follicular layer in
contact with blood flow and receives chemical informa-
tion from the peripheral nervous system [2].
Several studies in recent years indicate that the puriner-
gic signaling system is functionally expressed in the ovary
of several species [3] and represents another regulatory
element in ovarian physiology; however, the physiological
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Page 2 of 11role of ATP in this context and its membrane receptors is
unknown.
ATP is an important neurotransmitter in the peripheral
nervous system [3], and nerve terminals from this system
are potential sources for ATP release in the ovary. For
example, the ovary is innervated by sympathetic termi-
nals through the superior ovarian nerve and ovarian
plexus [2,4]. It has been shown in other tissues that ATP
is co-released with noradrenaline by sympathetic termi-
nals and that it participates in several physiological
events such as the induction and regulation of smooth
muscle contraction [5] and the modulation of cardiac
muscle excitation [6]. In addition, several cell types are
able to release ATP in a basal manner and/or in response
to different stimuli, such as mechanical stimulation,
changes in pH, or hypotonic stress [7-9].
As a cellular messenger, ATP exerts its action through
membrane receptors named P2, which are grouped into
two subfamilies: P2X receptors that are cationic channels,
and P2Y receptors that belong to the G protein-coupled
receptor (GPCR) super family. In mammals, 8 subtypes of
P2Y receptors have been described: 1, 2, 4, 6, and 11-14.
Subtypes P2Y1, 2, 4, 6, and 11 are mainly coupled to Gαq/
11 proteins, and they activate phospholipase C (PLC) and
consequently diacylglycerol and phosphoinositide-Ca2+
turnover; subtypes 12-14, on the other hand, are coupled
to Gαi/0 proteins that signal primarily by inhibiting adeny-
lyl cyclase [10].
P2Y2, P2Y4, and P2Y6 form a subgroup of receptors
sensitive to uridine nucleotides [11]; P2Y2 and P2Y4
show selectivity for nucleoside triphosphates, while P2Y6
prefers mainly nucleoside diphosphates, specifically UDP
[12]. Uridine P2Y-activated receptors are involved in a
broad variety of physiological processes such as cell pro-
liferation, smooth muscle contraction, transmitter
release, and others [3,10]. In the ovary, expression of
UTP-sensitive P2Y receptors has been described in gran-
ulosa luteal cells [13,14], in the cumulus cell-oocyte com-
plex [15], and in Xenopus ovarian follicles [16,17].
Recently, it was demonstrated that functional P2X7
receptors are expressed in mammalian TIC and can
induce apoptotic cell death [18]. In the same study, it was
also observed that the application of UTP evoked intrac-
ellular [Ca2+]i changes, suggesting that multiple P2 recep-
tor subtypes are expressed in theca cells. Here, we studied
this response in order to elucidate in more detail the
molecular elements involved and the physiological impli-
cations of their activation. We found that uridine-sensi-
tive P2Y2 and P2Y6 receptors are expressed in the TIC
membrane and that P2Y activation promoted three
important responses in these cells: 1) elicited Ca2+ mobili-
zation from intracellular reservoirs, increasing the con-
centration of this important second messenger in the
cytoplasm; 2) increased cell proliferation through a
mechanism dependent on the activation of protein kinase
C (PKC) as well as MAPK p44 and p42, and; 3) down reg-
ulated hCG-dependent phosphorylation of CREB, an
important element in steroidogenesis cascade control.
Methods
Materials
ATP, UTP, UDP, suramin, human chorionic gonadotropic
hormone (hCG), porcine follicle stimulating hormone
(FSH), and PPADS were purchased from Sigma Chemical
Co. (St. Louis, MO), and staurosporin, wortmanin, and
phorbol 12-myristate 13-acetate (PMA) were from Cal-
biochem (Gibbstown, NJ). DMEM-F12 medium, fetal
bovine serum, antibiotic-antimycotic mix, and other cell
culture reagents were from Gibco Invitrogen Co. (Grand
Island, NY). Antibodies against mouse total or phospho-
rylated MAPK p44 and p42 and total or phosphorylated
CREB were from Cell Signaling (Danvers, MA), and anti-
body against poly(ADP-ribose) polymerase-1 (PARP) was
from Santa Cruz Biotechnology (Santa Cruz, CA). Oligo-
nucleotides, reverse transcriptase, oligo dT, taq poly-
merase, and other molecular biology reagents were
purchased from Invitrogen Co. (Carlsbad, CA), and
Fluo4-AM was from Molecular Probes Invitrogen Co.
(Eugene, OR). Automatic sequencing was done in the
Molecular Biology Unit of the Instituto de Neurobiología,
UNAM.
Theca cell isolation and culture
Mouse theca/interstitial cells were purified by a discon-
tinuous Percoll gradient [19,20]. Immature mice were
used to avoid cultures enriched in luteal cells. Thus,
intact 4- to 5-week-old mice of the strain C57 were sacri-
ficed by cervical dislocation, a procedure approved by the
ethical committee of Instituto de Neurobiología-UNAM.
The ovaries were dissected and incubated in collagenase
(100 mg/ml) for 20 min, and the ovarian epithelium was
removed by passing the complete ovary repeatedly in and
out through the orifice of a Pasteur pipette. Most granu-
losa cells were then eliminated by puncturing the iso-
lated, epithelium-free ovaries with a fine hypodermic
needle. The ovary, free of epithelium and most granulosa,
was cut into fine pieces that were then incubated in a mix
of collagenase (4 mg/ml), DNase I (10 μg/ml), and BSA
(10 mg/ml) for 30 min. The homogenate was fractioned
on a discontinuous gradient: bottom layer 44% Percoll;
top layer Percoll of density 1.055 g/ml. The cells were
centrifuged for 20 min at 400 × g, and TIC were collected
from the interface by aspiration, then cultured in DMEM-
F12 medium containing 10% fetal bovine serum supple-
mented with antibiotic-antimycotic at 37°C in a humidi-
fied atmosphere with 5% CO2. Cultures were maintained
48 h before using them in experiments, to allow proper
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we usually obtained 1 × 106 cells per mouse; purity was
assayed by RT-PCR and immunocytochemistry against
CYP11A protein (> 96% of cells were positive). To exclude
contamination with granulosa, the expression of the FSH
receptor transcript and the responsiveness of CREB
phosphorylation to hCG or FSH were assayed.
Reverse Transcription Polymerase Chain Reaction
Total RNA of TIC cultures or from the indicated organ
was purified using the guanidine isothiocyanate method
[21]. First strand cDNA was synthesized using 2 μg of
DNase-treated RNA as template, 1 mg of oligo(dT), ran-
dom hexamers, and reverse transcriptase.
The cDNA was used as template in a polymerase chain
reaction to amplify cDNA fragments for β-actin, p2y2r,
p2y4r, and p2y6r transcripts, and for cyp11A, cyp17A,
star, and fshr as positive and negative theca cell markers,
respectively. All the PCR programs started at 96°C for 3
min and finished at 72°C for 1 min. The amplification
cycles consisted in 40 s at 96°C, 40 s at the specific
annealing temperature for each primer set, and 40 s at
72°C.
The sequences of the oligonucleotides, the annealing
temperatures, and the number of PCR cycles used were
as follows: p2y2r, forward GGACGAACTGGGATA-
CAAGTGT, reverse GTGGACTCTGTCCGTCTT-
GAGT, annealing temperature 55°C, 30 cycles; p2y4r,
forward GGGACTAACTGCAGGCAGAG, reverse
GATACACATCAGGCCCGTCT, annealing temperature
60°C, 40 cycles; p2y6r, forward TTTCAAGCGACTGCT-
GCTAA, reverse TGGCATAGAAGAGGAAGCGT,
annealing temperature 55°C, 30 cycles; cyp11A, forward
GCTGGAAGGTGTAGCTCAGG, reverse CACTGGT-
GTGGAACATCTGG, annealing temperature 55°C, 30
cycles; cyp17A, forward TGGTCGGCCCCAGATG-
GTGA, reverse ATCTCGGGACTCCCCGTCGT,
annealing temperature 56°C, 30 cycles; star, forward AA
CCAGGAAGGCTGGAAGAAG, reverse AGCAGC-
CAAG TGAGTTTAGTC, annealing temperature 55°C,
30 cycles; fshr, forward TGGATGTCATCACTGGCTGT,
reverse CAAATCTCAGTTCAATGGCG, annealing tem-
perature 58°C, 30 cycles; and β-actin, forward GGGTCA-
GAAGGATTCCTATG, reverse GGTCTCAAACATGAT
CTGGG, annealing temperature 55°C, 25 cycles.
The amplified products were gel-isolated, phenol-chlo-
roform purified, and subcloned into the pCR4-TOPO
vector (Molecular Probes Invitrogen Co.). Their nucle-
otide sequences were confirmed by automatic sequenc-
ing.
Fluorescence microscopy
Mouse ovarian TIC were grown on 12-mm diameter
cover slides. Semi-confluent cultures were loaded for 15
min with 5 mM fluo-4/AM and 0.1% pluronic acid in
Krebs solution (in mM: 150 NaCl, 1 KCl, 1 MgCl2, 1.5
CaCl2, 4 glucose, 10 HEPES, and 0.05% BSA, pH 7.4). The
cells were washed with Krebs solution for 10 min to elim-
inate excess dye and then placed in a constant-flow
recording chamber that allowed them to be visualized
with an inverted fluorescence microscope (Olympus
IX70, Melville, NY). Drugs were applied by superfusion
and responses were recorded with an Evolution QEi cam-
era (Media Cybernetics, Bethesda, MD). Sequences of
images were analyzed using the Image-Pro Plus software
(Media cybernetics, Bethesda, MD) and Imagenes soft-
ware, a program developed specifically for this analysis
(Dr. Ivan Terol, CIDETEQ, México). In the Ca2+-free
Krebs solution, CaCl2 was replaced by 3 mM MgCl2.
Western blot
For MAPK p42 and p44 or CREB phosphorylation exper-
iments, cultured TIC (5 × 105) were harvested 24 h before
the experiment to reduce serum-dependent kinase activ-
ity. After that, cells were stimulated with the indicated
drugs, scraped in Laemmli buffer, and boiled for 5 min.
For electrophoresis, samples were fractionated in a 10%
SDS-polyacrylamide gel and transferred to a nitrocellu-
lose membrane (BioRad, Hercules, CA). Membranes
were blocked for 1 h at room temperature in 150 mM
NaCl, 20 mM Tris, pH 7.4, and 0.1% Tween 20 (TBS-T)
containing 5% nonfat dry milk and then incubated over-
night at 4°C with the appropriate rabbit primary antibody
(1:1000) directed against the phosphorylated form of
MAPK p44 and p42 or CREB (Cell signaling, Danvers,
MA). After washing with TBS-T, membranes were incu-
bated 1 h at 37°C with HRP-conjugated goat anti-rabbit
antibody (Zymed, Invitrogen Co., Grand Island, NY) in
TBS-T. The immunoreactive proteins were detected by
chemiluminescence, and images were analyzed by pixel
density with ImageJ Software (NIH, USA); the results
were expressed in terms of optic density normalized
against the basal condition, a parameter that is propor-
tional to the change in protein phosphorylation. To ana-
lyze total p44/p42 or other load controls, such as PARP,
the same membranes were incubated for 30 min in strip-
ing solution (50 mM, Tris pH 6.8, 100 mM β-mercapto-
ethanol, and 2% SDS) at 55°C, washed twice with TBS-T,
and then reprobed with a primary antibody against the
indicated protein.
Immunoprecipitation
TIC (1 × 106) were scraped in ice-cold TNTE buffer (Tris-
HCl pH 7.4,150 mM NaCl, 50 mM and 0.5 mM EDTA)
containing 5% Triton X-100 and a protease inhibitor
cocktail (Roche Co., Basel, Switzerland); the lysate was
centrifuged for 10 min at 14,000 rpm at 4°C, and the solu-
ble fraction was incubated overnight with 3 μl of anti-
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50 μl of protein G agarose was added to the lysate and
incubated for 1 h at room temperature; the agarose beads
were washed 3 times with TNTE containing 1% Triton X-
100 and protease inhibitors, resuspended in Laemmli
buffer, boiled for 5 min, and analyzed by Western blot.
Proliferation assay
Cell proliferation was analyzed using [3H]-thymidine
incorporation. For this, cells (104) were cultured in 48-
well plates and after 48 h of culture, they were harvested
and incubated for 24 h in serum-free DMEM-F12 media;
then the culture medium was changed to DMEM-F12
with 0.1% fetal bovine serum containing the experimental
treatment (UTP, UDP, or ATP at the indicated concentra-
tion). Then cultures were incubated for another 48 h,
with the addition of 1 μ Ci/well of [3H]-thymidine after
the first 24 h. At the end of the incubation, each well was
washed 3 times with 5% trichloroacetic acid, and then the
cells were lysed by addition of 250 μl of boiling 250 mM
NaOH, incubated 5 min, and transferred to vials contain-
ing 5 ml of scintillation liquid. Samples were counted in a
scintillation counter.
Statistical analysis
All data are expressed as mean ± S.E.M. Statistical analy-
sis was performed using GraphPad Prism (La Jolla, CA)
software. The means of two groups were compared using
a Student's t-test. ANOVA was used to compare several
groups, and differences were considered to be significant
at p < 0.05.
Results
Theca cell identity and expression of P2Y2, P2Y4, and P2Y6 
receptors
TIC were isolated, and their identity was confirmed by
RT-PCR amplification of cyp11A, cyp17A, and star tran-
scripts as specific markers for theca cells, and of FSH
receptor (fshr) transcripts as indicator of a possible con-
tamination with granulosa cells; the β-actin transcript
was used as a control housekeeping gene (Figure 1A). The
results showed that TIC cultures were positive for
cyp11A, cyp17A, and star expression, but they did not
express the FSH receptor, demonstrating that the isolated
cells were mainly of the thecal/interstitial type and were
essentially free of granulosa cells.
This conclusion was strengthened with data obtained
in functional experiments. For this, TIC cells were stimu-
lated by 2 IU hCG or 1 ng/ml FSH, and CREB phosphory-
lation was evaluated. It is well established that
gonadotropin receptors exert their actions by coupling to
G proteins, increasing cAMP synthesis that, in conse-
quence, promotes CREB-phosphorylation [22,23]. It was
found that in TIC cultures, CREB protein-phosphoryla-
tion (43-kDa band) was increased 6-fold by hCG stimula-
tion, whereas FSH did not induce any change (Figure 1B),
thus supporting the idea that these cultures contained
mainly theca/interstitial cells.
To study the expression of p2y2r, p2y4r, and p2y6r tran-
scripts, RNA from TIC was reverse transcribed, and then
PCR was carried out with specific oligonucleotides for
each receptor subtype. RNA samples from ovary, brain,
and heart were also analyzed as controls. As shown in
Figure 1A, a p2y2r fragment of 1032 bp and a p2y6r frag-
ment of 257 bp were amplified from the cDNA of all tis-
sues tested. However, the p2y4r fragment of 575 bp was
only amplified from the whole ovary and brain cDNA. In
all the assays, control amplifications without RT or with-
out cDNA template did not produce any PCR product
(Figure 1A). The amplified fragments were cloned into
the pCR4-TOPO vector, sequenced, and analyzed in
BLAST, and the fragments were identical to the reported
sequences from mouse (NM008773 for p2y2r, NM020621
for p2y4r, and NM183168 for p2y6r).
These RT-PCR results indicated that TIC might express
P2Y2 and P2Y6 receptors. In order to detect the protein,
Western blot was performed from homogenates to detect
P2Y2; to detect P2Y6 receptor it was necessary to per-
form immunoprecipitation followed by Western blot,
Figure 1 p2y2r, p2y4r, and p2y6r expression in mouse theca cells. 
(A) RNA from cultured theca cells (1), whole ovary (2), heart (3), and 
brain (4) was reverse transcribed and amplified by PCR for p2Y2, p2Y4, 
p2Y6, cyp11A, cyp 17A, star, fshr, and β-actin using specific oligonucle-
otides to detect transcript expression. Controls in lanes (5) and (6) cor-
respond to a PCR reaction of a theca cell RNA sample without reverse 
transcriptase and to the reaction mix without a cDNA template, re-
spectively. Amplicon length is indicated in base pairs (bp). Each ampli-
fication assay was repeated in 3-5 independent cultures. (B) CREB 
phosphorylation evaluated by Western blot from TIC cultures in basal 
conditions or stimulated for 10 min by either 2 IU hCG or 1 ng/ml FSH. 
The 43-kDa band was analyzed by densitometry, and the result (mean 
± S.E.M) of three determinations from independent cultures was plot-
ted (*p < 0.01). PARP protein was used as gel loading control. (C) P2Y2 
and P2Y6 receptors detected by Western blot (WB), from freshly isolat-
ed TIC homogenates directly (P2Y2) or after immunoprecipitation (IP) 
(P2Y6).
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(Figure 1C). P2Y2 was detected as a band of 58 kDa, a
major band near 70 kDa, and a fainter band of 45 kDa.
P2Y6 was detected as three bands with molecular weights
of approximately 45, 40, and 37 kDa. In the latter case, the
IgG heavy chain interfered with the immunoreactive
bands corresponding to the receptor. However, all bands
observed match the molecular weights reported previ-
ously for both receptor types [e.g., [24,25]].
UTP- and UDP-induced increase of intracellular Ca2+ 
concentration in TIC
Functional responses of P2Y receptors were studied by
applying ATP, UTP, or UDP to TIC and monitoring the
changes in intracellular calcium concentration ([Ca2+]i)
using fluorescence microscopy of Fluo-4-AM loaded-
cells. In all cases, 25 to 40 cells from 3 independent cul-
tures (each from 2 donors) were analyzed (Figure 2).
Figure 2A shows a typical response elicited by 100 μM
ATP. At the highest concentration tested (1 mM), ATP
elicited a [Ca2+]i increase of 458 ± 18% compared with the
basal level (Figure 2B, left panel); this increase was mono-
tonic (Figure 2B, right panel), dose-dependent, and had
an EC50 of 6.5 ± 1.0 μM. In cells from the same cultures,
UTP also induced a dose-dependent response with an
EC50 of 3.5 ± 1 μM and a maximal increase of 437 ± 12%
(Figure 2C, left panel). As illustrated in the right panel,
the increase generated by UTP had a similar time-course
to that elicited by ATP.
Three types of P2Y receptors sensitive to UTP have
been described: P2Y2, P2Y4, and P2Y6 receptors. UDP is
a more potent agonist for P2Y6 receptors than UTP or
ATP; thus, in order to detect a possible participation of
P2Y6, TIC were tested with UDP. This nucleotide elicited
responses with an EC50 3.2 ± 0.8 μM; however, the maxi-
mal response reached was only 210 ± 5.4% (Figure 2D, left
panel). Furthermore, the [Ca2+]i increase in response to
UDP consistently showed an oscillating time-course (Fig-
ure 2D, right panel), different from that observed with
ATP or UTP.
In the absence of extracellular Ca2+ (Ca2+-free solution),
responses to either UTP or UDP were not abolished (Fig-
ure 2E). Nevertheless, maximal responses generated by
UTP averaged 366 ± 13%, significantly less (P < 0.01) than
those observed in normal Krebs solution (437 ± 12%).
The EC50 obtained for UTP in Ca2+-free solution was 6.2
± 0.9 μM and was not significantly different from that
obtained in normal Krebs. For UDP, similar findings were
observed: the maximal response reached 230 ± 15% and
had an EC50 of 4.9 ± 0.6 μM; neither parameter differed
significantly from that in normal Krebs.
This suggested that extracellular Ca2+ was not the
major source of the [Ca2+]i increase produced in TIC by
UTP or UDP; more probably, this increase came from
intracellular reservoirs via IP3 synthesis, as shown in
other cell systems.
UTP-induced activation of p44 and p42 MAPK
In order to study the signaling pathway involved in the
UTP and UDP activation of P2Y receptors in TIC, phos-
phorylation of the p44 and p42 MAPK proteins was eval-
uated (in at least 3 experiments, each in duplicate, carried
out on independent cultures derived from pooled ovaries
of 2-3 mice). For these experiments, UTP was used as a
specific agonist of the P2Y receptor subtypes studied. It
Figure 2 Dose-response (D-R) relationships and time course of in-
tracellular Ca2+ responses generated by ATP, UTP, or UDP in TIC 
cells. (A) Images show a typical fluorescence increase of theca cells 
loaded with Fluo4-AM dye upon stimulation with 100 μM ATP at 0, 10, 
or 40 s. (B) D-R relationship (left panel) for the intracellular Ca2+ increase 
elicited by ATP, expressed as a percent of the basal level of arbitrary 
units of fluorescence (AUF), and time course of the response elicited by 
1 mM ATP (right panel). (C) and (D) show experiments similar to those 
in (B) but applying UTP or UDP, respectively, instead of ATP. (E) D-R 
curves of the theca cell response to UTP (left) or UDP (right) in Ca2+-free 
Krebs. The stimulus was applied at the time indicated by an arrow and 
was maintained to the end of the recording. Data points represent the 
mean ± S.E.M. from 25 to 40 cells in each of 3 independent experi-
ments.
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in a dose-dependent manner with an EC50 of 3.3 ± 0.9 and
1.4 ± 0.7 μM for p44 and p42, respectively; maximal
increases of 541 ± 25.6% and 461 ± 34.8%, respectively,
were observed by applying 100 μM UTP (Figure 3A). The
time course of this effect was studied by applying 10 μM
UTP and measuring p44 and p42 MAPK phosphoryla-
tion at different times. The results indicated that maximal
phosphorylation occurred at 5 min of stimulation, and
then it decreased slowly, returning to near-basal levels
about 30 min after UTP addition (Figure 3B).
Because it has been shown consistently that UDP acts
more potently on P2Y6 receptors [11,12], its ability to
promote p44 and p42 MAPK phosphorylation was tested.
In experiments similar to those presented above for UTP,
100 μM UDP was less potent and induced only modest
responses of 199 ± 43% and 158 ± 15% for p44 and p42,
respectively, compared to the basal level; the effect
increased to 364 ± 63% and 349 ± 95%, respectively, with
1 mM UDP (Figure 3C). The time course of p44/p42
phosphorylation induced by 1 mM UDP was similar to
that elicited by 100 μM UTP (Figure 3D). In addition, the
p44 and p42 MAPK phosphorylation induced by 10 μM
UTP was antagonized by suramin with an IC50 of 84.3 ±
10.2 μM (Figure 4A); suramin is a potent antagonist of
P2Y2 receptors but is only a weak antagonist of P2Y6
[11]. Conversely, PPADS up to 600 μM, a drug that antag-
onizes mainly the P2Y6 receptor [11], had no effect on
UTP-induced MAPK phosphorylation (Figure 4B). These
results suggested that P2Y6 is not a major participant in
the phosphorylation of MAPK; in consequence, the fol-
lowing experiments focused on defining the role of the
P2Y2 receptor in the purinergic response.
UTP-induced p44 and p42 MAPK phosphorylation is 
dependent on PKC activation
UTP-dependent p44/p42 MAPK phosphorylation might
be elicited via either of two main mechanisms: 1) transac-
tivation of EGF receptors as has been demonstrated, for
example, in salivary gland cells [26] or 2) by activation of
kinases through its canonical pathway. However, EGF
transactivation requires long-term (over 1 h) stimulation
with the agonist, and activation of p44/p42 MAPK in TIC
was generated even with short incubations; thus, it was
decided to analyze first the role of down stream kinases.
Two of the main candidate protein kinases, PKC and
PI3K [27,28], were blocked using specific pharmacologi-
cal tools. PI3K activation was blocked by preincubation
for 30 min with the selective inhibitor 100 nM wortmanin
(Figure 5A) or with 1 μM LY294002 (not shown) before
stimulating the cells with 10 μM UTP; under these condi-
Figure 3 D-R relationships and time course for the phosphoryla-
tion response elicited by UTP or UDP on p44 and p42 MAPK. (A) 
Phosphorylated isoforms of p44 (black dots) or p42 (white dots) were 
immunodetected (Western blot) in samples of theca cells that were 
stimulated with various UTP concentrations. The band intensities (OD) 
are expressed as a percent of the basal level, and the values were used 
to plot the D-R relationship. (B) Time course of the p44 and p42 phos-
phorylation process elicited by 10 μM UTP. (C) D-R for phosphorylation 
elicited by UDP in experiments similar to those in (A). (D) Time course 
of p44 and p42 phosphorylation elicited by 1 mM UDP. Data points are 
the mean ± S.E.M. of three independent experiments.
Figure 4 p44 and p42 MAPK phosphorylation induced by UTP is 
blocked by suramin but not by PPADS. Cultures of mouse theca 
cells were incubated for 30 min with suramin (A) or PPADS (B) at the in-
dicated concentrations; subsequently, 10 μM UTP was applied for 5 
min, and p44 (black dots) and p42 (white dots) MAPK phosphorylation 
was detected by Western blot. Data points are the mean ± S.E.M. of 
three independent experiments.
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MAPK phosphorylation (n = 3 independent cultures).
To study the possible participation of PKC, TIC cul-
tures were preincubated (30 min) with 250 nM stauro-
sporine and then tested with 10 μM UTP. Staurosporine
treatment blocked completely the UTP-stimulated p44
and p42 phosphorylation (Figure 5A), strongly suggesting
that phosphorylation was dependent on PKC. To support
this idea, experiments were carried out in which PKC
activity was downregulated by long-term incubations
with phorbol-12-myristate-13-acetate (PMA) [29]. Thus,
TIC were pretreated for 18 h with 1 μM PMA, which did
not affect the basal levels of phosphorylated p44 or p42
proteins; cells were then stimulated with 10 μM UTP.
Under these conditions, PMA preincubation reduced p44
and p42 MAPK phosphorylation induced by UTP from a
maximal response without PMA of 347 ± 58% and 299 ±
56% for p44 and p42, respectively, to 164 ± 16% and 210 ±
43% (p < 0.05) (Figure 5B). These results indicate that
PKC is the main kinase responsible for the UTP-induced
activation of the p44 and p42 proteins.
To test the role of intracellular Ca2+ during p44 and p42
MAPK phosphorylation, cell cultures were preincubated
(90 min) with 10 μM BAPTA-AM to load the cells intrac-
ellularly with this Ca2+ chelator. Fluorescence microscopy
confirmed that this treatment prevented the calcium
increase induced by UTP. In BAPTA-loaded TIC, phos-
phorylation of MAPK elicited by UTP was strongly inhib-
ited (Figure 6); thus, in control conditions, UTP elicited a
phosphorylation increase of 384 ± 53 and 289 ± 55% for
p44 and p42, respectively, while UTP-stimulated BAPTA-
loaded cells showed significantly (p < 0.05) lower phos-
phorylation increases of only 171 ± 40 and 116 ± 16%,
respectively. This result indicates that phosphorylation
was a Ca2+-dependent process and provides evidence for
PKC participation.
Evidence that suggests a role for purinergic signaling in TIC 
physiology
Cell proliferation is a consequence of purinergic stimula-
tion in various cell systems [3]; here we asked whether or
not P2Y stimulation of TIC induced their proliferation.
For this, cell cultures were stimulated with different con-
centrations of UTP, ATP, or UDP; cell proliferation was
estimated using [3H]-thymidine incorporation and com-
pared with that elicited by 10% FBS (Figure 7 shows four
independent determinations, each in triplicate, from cul-
tures where the ovaries of 2-3 mice were pooled).
The results indicated that ATP, UTP, or UDP increased
proliferation. Incubation with 10% FBS increased [3H]-
thymidine incorporation to 277 ± 23% of the basal level,
and a similar increase was induced by 10 μM ATP (232 ±
33%) but not by 100 μM ATP (135 ± 13%). Also, 100 μM
UTP or UDP induced robust responses of 205 ± 18% and
221 ± 17%, respectively, while at 1 mM they generated
Figure 5 Effect of protein kinase inhibitors on p44 and p42 MAPK 
phosphorylation induced by UTP. (A) Western blot detection of 
phosphorylated p44 (white columns) and p42 (black columns) MAPK 
in the presence of 100 nM wortmanin or 250 nM staurosporine in theca 
cells stimulated or not with 10 μM UTP (5 min). In (B), down regulation 
of PKC was induced by an overnight (18 h) cell incubation with 1 μM 
PMA, and then phosphorylation of p44 and p42 MAPK was assayed for 
cells treated or not with 10 μM UTP (5 min). Data points represent the 
average optical density (± S.E.M.) of three independent experiments 
expressed as a percent of the basal level (*p < 0.05 vs. UTP, one-way 
ANOVA and Bonferroni's test).
Figure 5
Figure 6 Effect of intracellular BAPTA loading on p44 and p42 
MAPK phosphorylation induced by UTP. Cultures of mouse theca 
cells were preincubated for 90 min with 10 μM BAPTA-AM; cells were 
then stimulated for 5 min with 10 μM UTP and assayed for phosphory-
lation of MAPK p44 (white columns) and p42 (black columns). Ampli-
tude bars in the plot represent the mean ± S.E.M. of three independent 
experiments (*p < 0.05 vs. UTP, one-way ANOVA and Bonferroni's test).
Figure 6
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Page 8 of 11increases of 216 ± 37% and 183 ± 23%, respectively. The
results strongly suggested that P2Y receptors were able to
activate a proliferative response in TIC.
The possibility of regulatory cross talk between P2Y2
and LH receptors was also examined. First, it was shown
that TIC responded to a 2 IU hCG stimulus by increasing
CREB phosphorylation, and this response reached a max-
imum in 10 min (figure 7B). This observation demon-
strated that the LH receptor efficiently activated the
cAMP pathway in TIC cultures (see figure 1B). It is well
established that the cAMP/PKA/CREB pathway partici-
pates in the canonical signal transduction cascade for
regulation of androgen biosynthesis through the LH
receptor [22].
With this rationale, cultures of TIC were incubated in 0,
10, or 100 μM of UTP for 10 min, then 2 IU hCG were
added for 10 min more, cell lysates were obtained, and
CREB phosphorylation was evaluated by Western blot as
an indicator of LH receptor activity. It was found that
UTP, either 10 or 100 μM, completely blocked CREB
phosphorylation (figure 7C), strongly suggesting that
P2Y2 receptor stimulation inhibited the cAMP pathway
activated by LH. This raises the possibility that the puri-
nergic system participates in regulating the physiological
actions promoted by LH, for example, the steroid hor-
mones synthesis pathway.
Discussion
It has been recognized that neurotransmitters might play
distinct, regulatory roles in ovarian physiology; for exam-
ple, it has been proposed that, in addition to the regula-
tory actions of gonadotropins, the activity of sympathetic
fibers that innervate the ovary controls different aspects
of ovarian function, such as steroidogenesis, folliculogen-
esis, and ovulation [e.g., [30,2,31,32]]; most of these stud-
ies have examined the role of the catecholaminergic
system and specifically, of norepinephrine [30-32], but
there is also a great deal of important evidence for partic-
ipation of an ovarian cholinergic system [33,34].
Although knowledge about the purinergic system in the
ovary is scarce, it is well established that ATP and norepi-
nephrine are co-released at similar concentrations from
sympathetic terminals in many cell systems [5,7], and
release of ATP by the oocyte has already been docu-
mented in other species [8,16]. Thus, the study in the
ovary of the molecular components expressed and cellu-
lar mechanisms activated by the purinergic system will be
of importance to understand the possible role of ATP in
ovarian physiology and pathology. Here, we present clear
evidence of functional expression of UTP-sensitive P2Y
receptors in TIC cultures, suggesting a role for these
receptors in ovarian physiology.
RT-PCR and Western blot studies indicated that cul-
tured TIC express P2Y2 and P2Y6 receptors. In func-
tional experiments, UTP and UDP, specific agonists for
P2Y2 and P2Y6, respectively, induced robust Ca2+ signals
in normal Krebs or in Ca2+-free solution, which indicated
that the nucleotides promoted the response mainly
through Ca2+ release from intracellular reservoirs, in
agreement with the canonical Gαq-PLC pathway for
these receptors [10]. UTP or high concentrations of UDP
(1 mM) also induced the phosphorylation of MAPK p44
and p42; at high concentrations, UDP acted principally
on the P2Y2 receptor, since P2Y6 is stimulated by UDP in
the low μM range [11]. Phosphorylation of MAPK was
inhibited by suramin, a potent antagonist for P2Y2 and
weak for P2Y6, but it was not affected by PPADS, which is
inactive toward P2Y2 but able to antagonize P2Y6 activa-
tion [11]. Taken together, our data indicated a main role
of the P2Y2 receptor in MAPK activation. There is ample
evidence that these protein kinases are involved in the
proliferative phenomenon activated by G protein-cou-
pled receptors in various cell systems [e.g., [27,28]]; in
addition, p44 and p42 MAPK activation dependent on
P2Y2 or P2Y6 receptors has been described, e.g., in gran-
ulosa-luteal cells [14], glioma cells [35], and embryonic
Figure 7 Proliferative response and inhibition of hCG-induced 
CREB phosphorylation by P2Y agonists in mouse theca cells. The-
ca cells were stimulated for 48 h with UTP, UDP, or ATP using the indi-
cated concentrations (log M); controls corresponded to cells 
incubated in media supplemented with 0.1% serum (basal) or with 
10% FBS (S). Cell proliferation was evaluated by [3H]-thymidine incor-
poration, data are the mean ± S.E.M. of 4 independent determinations. 
B) Time-course of CREB phosphorylation in TIC induced by 2 IU hCG; 
the 43-kDa band was quantified as in Figure 1B showing that maximal 
effect was reached in 10-15 min of incubation. C) CREB-phosphoryla-
tion elicited by 2 IU hCG in TIC incubated for 10 min in basal conditions 
and in the presence of 0, 10, or 100 μM UTP; the 43-kDa band was 
quantified as in B), data are from 3 independent experiments in tripli-
cate. (*p < 0.05 vs. basal, one-way ANOVA and Bonferroni's test).
Figure 7
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Page 9 of 11stem cells [36]. Staurosporin or long-term (18 h) incuba-
tion with PMA blocked UTP-induced p44 and p42
MAPK phosphorylation. In addition, p44 and p42 MAPK
phosphorylation was blocked in BAPTA-loaded cells,
strongly suggesting that a calcium-dependent PKC par-
ticipates in this response.
Activation of MAPK p44 and p42 is directly related to
induction of cell proliferation [37]. Our results demon-
strated that UTP and UDP induced a robust proliferative
response similar to that of 10% FBS used as positive con-
trol. ATP induced a proliferative response at 10 μM, but
no effect was observed with higher concentrations. This
supports the idea that P2Y2 is the main receptor involved
in the response, but an ancillary participation of P2Y6
cannot yet be excluded. The regulation of theca cell pro-
liferation is relevant during folliculogenesis [1], and it
might be involved in pathological processes, such as the
altered androgen-estrogen balance associated with poly-
cystic ovary syndrome, a common disease characterized
by uncontrolled theca cell proliferation [38]. In this con-
text, purinergic signaling can activate a feedback mecha-
nism by inducing a proliferative or an apoptotic response
in TIC.
ATP actions to stimulate TIC proliferation through
P2Y2 (and P2Y6) receptor activation should be taken into
account, together with the effects described for other
neurotransmitters that seem to regulate specific pro-
cesses in the ovary. For example, previous evidence
showed that human granulosa-luteal cells express M1 and
M5 muscarinic receptors [34] as well as P2Y2 purinergic
receptors [13,14]; stimulation of either system by acetyl-
choline or ATP can promote granulosa-luteal cell prolif-
eration. Stimulation of β-adrenergic receptors also
modulates steroidogenic activity and ovulation [31] and,
given that neurotransmitters released from cate-
cholaminergic terminals might include ATP, it would be
of interest to know the effect of activating purinergic
receptors in these processes.
The results also showed that P2Y2 receptor activation
had an important effect on the LH signaling pathway. It
has been shown before that LH induces CREB phospho-
rylation [22,39] and that expression of a dominant nega-
tive CREB variant was enough to block androgen
biosynthesis in rat TIC cells [22]. We observed that prein-
cubation with UTP (10 or 100 μM), completely blocked
the hCG-induced CREB phosphorylation, which suggests
that the purinergic system potently modulates LH-acti-
vated pathways, an action that might have important con-
sequences in ovarian theca physiology.
Is well known that during folliculogenesis LH exerts
regulatory actions beginning around the formation of
early secondary follicles, which is concurrent with theca
layer differentiation; from this stage throughout folliculo-
genesis up to ovulation, LH is the main regulator of theca
layer development, because it controls the steroidogene-
sis process [40]. However, during this period, important
phenomena such as follicular selection or dominance
processes cannot be explained solely by LH action; para-
crine and autocrine follicular molecules seem to be
essential for the final outcome [41]. It is possible that
P2Y2 activation represents one of the mechanisms by
which LH regulates the cohort of follicles that will or will
not become dominant. Thus, the process of purinergic
regulation demonstrated here might be involved in main-
taining the proper balance between the rate of cell divi-
sion and death in the ovary, and in essential physiological
actions such as steroidogenesis, functioning as a local,
fine-tuning modulator to complement the systemic con-
trol exerted by hormones and nervous system afferents.
Hence, purinergic regulation is a potential therapeutic
target in ovarian pathologies where proliferation or the
steroidogenesis processes are affected.
Specifically in regulating the balance between theca
proliferation and death, our data suggest that activation
of the purinergic system by ATP could have dual effects
on theca cell physiology; i.e., depending on the concen-
tration, ATP might induce: 1) apoptotic cell death
through P2X7 receptors (18) and 2) cell proliferation
through P2Y2/P2Y6 receptors, as shown here. This is
similar to what has been demonstrated in other systems
in which the cells seem to co-express multiple purinergic
receptor subtypes, leading to activation of multiple sig-
naling pathways. For example, macrophages express a
variety of P2X and P2Y purinergic receptors, and their
activation modulates diverse physiological process such
as apoptosis, activation of cell proliferation pathways, or
activation of the inflammatory response machinery
[42,43]. The final physiological outcome of the effect
exerted by ATP in a given process will be determined by
several factors including, for example, the purinergic
receptor affinities, source and availability of ATP, ecto-
ATPase activity, and also cross-talk between different G
protein-coupled receptor types or subunits of receptor
channels [see e.g., [17]]. In this context, it is important to
mention that high concentrations of ATP (0.1 - 1 mM),
but not of UTP, were consistently unable to increase cell
proliferation, which might be a result of P2X7 receptor
activation that can induce apoptotic cell death [18],
among other possibilities, such as a regulatory effect of
ATP on P2Y2/P2Y6 receptor function. Distinguishing
among the various possibilities will require further analy-
sis of the functional interaction among the different P2
receptors expressed in the ovarian theca.
Data presented in the present work are the first evi-
dence that UTP-sensitive P2Y receptors are expressed
and functional in theca cells. Although extensive studies
are necessarily to establish with detail the main physio-
logical activities, experimental data suggested these
Vázquez-Cuevas et al. Reproductive Biology and Endocrinology 2010, 8:88
http://www.rbej.com/content/8/1/88
Page 10 of 11receptors have a role in p44/p42 MAPK phosphorylation,
proliferation increase, and cross talk with LH-activated
pathways. These observations raise the possibility that
the purinergic signaling system represents an important
physiological regulator of theca cells.
Conclusion
In summary, it was shown here that TIC express func-
tional P2Y2 and P2Y6 receptors, which, when stimulated,
induce a Ca2+-dependent proliferative response mediated
through PKC activation and phosphorylation of the p42
and p44 MAPK proteins. P2Y receptor stimulation also
regulates hCG-dependent CREB phosphorylation, sug-
gesting interactions between functional pathways.
Molecular components of purinergic transmission sys-
tems represent new molecular targets that must be char-
acterized in the context of ovarian pathophysiology.
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